This firm reports 222.23
M of total liabilities with total debt to equity ratio (D/E) of 44.9, which implies that NantHealth may not be able to produce enough cash to satisfy its debt commitments. NantHealth is OVERVALUED at 3.64 per share with modest projections ahead.
We determine the current worth of Nanthealth LLC using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nanthealth LLC based exclusively on its
fundamental and basic
technical indicators. By analyzing Nanthealth LLC's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of
Nanthealth LLC's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nanthealth LLC. We calculate exposure to Nanthealth LLC's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Nanthealth LLC's related companies.
Watch out for price decline
Please consider monitoring Nanthealth LLC on a daily basis if you are holding a position in it. Nanthealth LLC is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Nanthealth LLC stock to be traded above the $1 level to remain listed. If Nanthealth LLC stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Nanthealth LLC Investment Alerts
Nanthealth investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Nanthealth LLC performance across your portfolios.Please check all
investment alerts for Nanthealth
Nanthealth LLC Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare Nanthealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanthealth LLC competition to find
correlations between indicators driving the intrinsic value of Nanthealth.
What is the case for Nanthealth LLC Investors
The company generated the yearly revenue of 91.63
M. Annual Net Loss to common stockholders was (78.65
M) with gross profit of 62.2
M.
Margins Breakdown
NantHealth profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or NantHealth itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of NantHealth profit margins.
| Operating Margin | (55.03) |
| EBITDA Margin | (0.25) |
| Gross Margin | 0.6 |
| Profit Margin | (0.71) |
NantHealth Revenue Per Employee is increasing over the last 6 years. Moreover, NantHealth Earnings Before Interest Taxes and Depreciation Amortization EBITDA is nearly stable at the moment.
Over 3 percent rise for NantHealth. What does it mean for stockholders?
NantHealth current mean deviation boosts over 3.51. NantHealth exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate NantHealth individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about NantHealth future systematic risk.
Our Conclusion on NantHealth
While some other firms under the health information services industry are still a bit expensive, NantHealth may offer a potential longer-term growth to stockholders. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to exit some or all of your NantHealth holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to NantHealth.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Nanthealth LLC. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
